![](/img/cover-not-exists.png)
Phase I and pharmacodynamic study of Triapine®, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia
Francis J. Giles, Paula M. Fracasso, Hagop M. Kantarjian, Jorge E. Cortes, Randy A. Brown, Srdan Verstovsek, Yesid Alvarado, Deborah A. Thomas, Stefan Faderl, Guillermo Garcia-Manero, Lisa P. Wright,Volume:
27
Year:
2003
Language:
english
Pages:
7
DOI:
10.1016/s0145-2126(03)00118-8
File:
PDF, 107 KB
english, 2003